Dear Colleagues, We are happy to invite you to the 8th meeting of Pharmacometrics Network Benelux.
Please mark the following date and time in your agenda: When: Thursday, April 14th 2015 – 12:00 – 18:00 Where: hosted by KU Leuven, Belgium (Justus Lipsiuszaal at Faculteit Letteren) Blijde Inkomststraat, 21 3000 Leuven For information on parking, you can click this link: http://www.leuven.be/leven/mobiliteit-openbare-werken/parkeren/parkings/ Agenda theme: “Biomarkers or Clinical Endpoints? Or Both ?” Registration: you can already register by sending an e-mail to pharmacometrics-bene...@amc.uva.nl<mailto:pharmacometrics-bene...@amc.uva.nl> There is no registration fee, but registration is required for participation. You can register until April 8th. *** CALL FOR SPONSORS***: we are looking for organizations willing to fund this current meeting. We all appreciate the opportunity of the PMX BNL meetings for good science and good networking, please help us to keep it going. Please contact me (anne.broc...@ablynx.com<mailto:anne.broc...@ablynx.com>) if you want to participate. The meeting will include a light lunch, a coffee/tea break and drinks upon closure. Scientific Program To be announced *** CALL FOR PRESENTERS***: we are looking for volunteers to present some modeling work related to biomarkers and clinical endpoints modeling, please contact sross...@its.jnj.com<mailto:sross...@its.jnj.com> by February 19th if you want to participate. We hope to see you in Leuven on April 14th ! Pieter Annaert Anne Brochot Eugène Cox Thomas Kerbush Charlotte van Kesteren Ron Mathôt Stefaan Rossenu Laura Sargentini Jan-Stefan van der Walt On Pharmacometrics Network Benelux: the initiative aims to connect pharmacometricians in the Benelux (Belgium, Netherlands, and Luxembourg). The intention is to create an informal platform for the pharmacometrics community in this region of the world (in industry, academia, hospital pharmacies as well as regulatory bodies), with the goal to promote professional and scientific awareness and interactions. Stay tuned on our latest activity by joining our group on LinkedIn. ________________________________________ THIS E-MAIL MESSAGE IS INTENDED ONLY FOR THE USE OF THE INDIVIDUAL OR ENTITY TO WHICH IT IS ADDRESSED AND MAY CONTAIN INFORMATION THAT IS PRIVILEGED, CONFIDENTIAL AND EXEMPT FROM DISCLOSURE. If the reader of this E-mail message is not the intended recipient, you are hereby notified that any dissemination, distribution or copying of this communication is strictly prohibited. If you have received this communication in error, please notify us immediately at abl...@ablynx.com. Thank you for your co-operation. "NANOBODY" and "NANOCLONE" are registered trademarks of Ablynx N.V. ________________________________________
